HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions: A Randomized Clinical Trial.

AbstractBACKGROUND:
Benign bone cysts in children have a high risk of recurrence after bone grafting. The optimal treatment and filling material for these lesions are currently unknown.
METHODS:
We compared cyst recurrence after intralesional curettage and filling with allograft versus bioactive glass (BG-S53P4; Bonalive) in a randomized clinical trial. The volume of recurrent cyst at 2-year follow-up was the primary outcome.
RESULTS:
Of 64 eligible children, 51 (mean age, 11.1 years) were randomized to undergo filling of the cyst using morselized allograft (26) or bioactive glass (25). Twelve (46%) of the children in the allograft group and 10 (40%) in the bioactive glass group developed a recurrence (odds ratio [OR] for bioactive glass = 0.79, 95% confidence interval [CI] = 0.25 to 2.56, p = 0.77). The size of the recurrent cyst did not differ between the allograft group (mean, 3.3 mL; range, 0 to 13.2 mL) and the bioactive glass group (mean, 2.2 mL; range, 0 to 16.6 mL, p = 0.43). After adjusting for the type of lesion (aneurysmal bone cyst versus other), bioactive glass also did not prevent larger (>1 mL) recurrent cysts (adjusted OR = 0.42, 95% CI = 0.13 to 1.40, p = 0.16). The Musculoskeletal Tumor Society score improved significantly (p ≤ 0.013) from preoperatively to the 2-year follow-up in both groups (to 28.7 for bioactive glass and 29.1 for bone graft). Four (15%) of the children in the allograft group and 6 (24%) in the bioactive glass group required a reoperation during the follow-up (OR for bioactive glass = 1.74, 95% CI = 0.43 to 7.09, p = 0.50).
CONCLUSIONS:
Filling with bioactive glass and with allograft in the treatment of benign bone lesions provided comparable results in terms of recurrence and complications.
LEVEL OF EVIDENCE:
Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
AuthorsJohanna Syvänen, Willy Serlo, Jenni Jalkanen, Ia Kohonen, Arimatias Raitio, Yrjänä Nietosvaara, Ilkka Helenius
JournalThe Journal of bone and joint surgery. American volume (J Bone Joint Surg Am) Vol. 105 Issue 9 Pg. 659-666 (05 03 2023) ISSN: 1535-1386 [Electronic] United States
PMID36727973 (Publication Type: Randomized Controlled Trial, Journal Article)
CopyrightCopyright © 2023 by The Journal of Bone and Joint Surgery, Incorporated.
Topics
  • Humans
  • Child
  • Bone Cysts, Aneurysmal (surgery)
  • Bone Transplantation (methods)
  • Transplantation, Homologous
  • Allografts
  • Glass

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: